Like every year, the 2024 Work Plan (WP) of the European Health Program (EU4Health) also provides for the activation of Joint Actions (Joint Actions-JA) and Direct Funding (Direct Grants-DG), projects for which the participating organisations, that is, the Partners benefiting from the financing are designated directly by the Ministry of Health of the Member State.
It is expected that the European Commission will shortly send to the Ministries the request for the nomination of the participating organizations (National Coordinator – “Competent Authority” – CA; Affiliated Partner – “Affiliated Entity”) for each of the JA/DGs contained in the Work Plan (WP) 2024 of the EU4Health Programme.
Upon receipt, the Ministry of Health will publish on its Portal a specific invitation to submit applications, from the Organizations/Bodies that meet the requirements, for the roles of Applications as Competent Authority/Affiliated Entity.
While waiting for the official publication, interested organisations/bodies can already send a preliminary expression of interest via email to the following email address [email protected]
The methods and terms for the formal presentation of the Nominations as Competent Authority/Affiliated Entity will be published subsequently, in a document, together with the invitation to present the Nominations themselves; also in relation to the ongoing reform of the organization of the Ministry of Health, the document relating to the procedures of previous years will no longer be valid.
Below is the complete list of the 2024 JAs and DGs, with the references of the WP 2024 pages where the general contents, objectives and specific actions of each project are reported.
DP/CR-g-24-28 Cancers caused by infections, vaccine-preventable cancers and addressing communicable diseas (HIV/AIDS, Tubercolosis, Hepatitis) (p.15-18)
EU Co-Funding EUR 20.000.000
CR-g-24-36 Strengthening digital capabilities including e-health, telemedicine, remote monitoring systems, health data access and health data exchange services in cancer centres in the Union (p.19-22)
EU Co-Funding EUR 20.000.000
CR-g-24-41 Personalised Cancer Medicine (p. 23-25)
EU Co-Funding EUR 27.900.000
CP-g-24-13 Support to the development of sustainable, forward-looking national and Union stockpiling strategies (HERA) (p. 29-30)
EU Co-Funding EUR 10.000.000
DP-g-24-24 Promoting a comprehensive, prevention-oriented approach to mental health to support vulnerable groups (p. 34-38)
EU Co-Funding EUR 6.000.000
DP/CR-g-24-27 Health promotion and disease prevention including smoke- and aerosol- free environments (p.42-45)
EU Co-Funding EUR 16.000.000
DP-g 24-34 Supporting National Focal Point (“NFPs”) in providing guidance, information and assistance related to the promotion and implementation of the EU4Health Programme and other relevant legislation (p. 54-55)
EU Co-Funding EUR 2.000.000
CR-g-24-44 Paediatric palliative care (p. 56-58)
EU Co-Funding EUR 14.500.000
CR-g-24-40 Support quality improvement of cancer registry data feeding the European Cancer Information System (p. 65-67)
EU Co-Funding EUR 13.000.000
HS-g-24-54 Pricing and Reimbursement Authorities – to step up national work and collaboration in the group of National Competent Authorities on Pricing and Reimbursement and Public Healthcare Payers (“NCAPR”) (p. 82-84)
EU Co-Funding EUR 2.000.000
HS-g-24-104 Effective use of regulatory flexibilities including the use of magistral preparations that might be used to mitigate certain shortages (p. 85-86)
EU Co-Funding EUR 2.000.000
DGA DI-g-24-75 Expansion of MyHealth@EU (p. 89-90)
EU Co-Funding EUR 7.000.000
For further information, you can contact the Italian Focal Point, preferably by email: [email protected] or, alternatively, by telephone on 0659943173.
For further details and subsequent updates you can consult the pages of European Commission and those of HADEA.
Consultation: